(To be completed after the Algeria ICOM 2026)
Rethinking Cancer Care: Beyond the Tumor
Integrative Orthomolecular Systems Medicine (I-OM)
Richard Z. Cheng, MD, PhD
I-OM.ai | Columbia, South Carolina, USA
International Conference on Orthomolecular Medicine — Algeria 2026
Cancer Is More Than a Tumor. Care Must Address the Whole Patient.
Modern cancer medicine has achieved remarkable advances in diagnosis, surgery, radiation, immunotherapy, and targeted treatment.
Yet important questions remain:
Are we preventing enough cancers? Are patients living longer and healthier lives? And are the benefits of treatment worth the physical, emotional, and financial costs?
I-OM Systems Medicine advocates a more comprehensive approach—one that considers tumor biology alongside metabolic health, nutritional status, mitochondrial function, immune regulation, treatment resilience, and quality of life.
Our goal is to connect scientific research, responsible clinical innovation, and patient-centered care.
Explore the conference resources below.
01 | Complete Conference Keynote & References
Rethinking Cancer Care: Beyond the Tumor
[VIEW / DOWNLOAD COMPLETE KEYNOTE SLIDES — LINK PENDING]
Access the original Algeria cancer conference presentation, including scientific illustrations, supporting references, and additional reading.
Key topics
-
Why cancer prevention deserves greater attention
-
Early-onset cancer and emerging global health concerns
-
Successes and limitations of contemporary oncology
-
Precision oncology: response versus durable survival
-
Treatment-related harm and second primary cancers
-
Quality of life and financial toxicity
-
Cancer metabolism, mitochondrial biology, and host health
-
I-OM Systems Medicine and integrative cancer care
Professional educational material for clinicians, scientists, students, and interested members of the public.
02 | Featured Research — Latest Cancer Preprint (2026)
Unresolved Problems in Contemporary Cancer Medicine: Prevention Gaps, Limited Durable Benefit, Treatment-Related Harm, Quality of Life, and Financial Toxicity
Richard Z. Cheng, MD, PhD
Are we measuring cancer progress by what matters most to patients?
This critical narrative review examines seven major unresolved problems in cancer medicine:
1. Prevention gaps and early-onset cancer
Why are selected cancers increasing among younger adults, and what can be done to strengthen prevention?
2. Limited durable benefit
Despite major advances, long-term outcomes remain poor for many advanced malignancies.
3. Precision oncology limitations
A promising molecular target, drug approval, or tumor response does not automatically translate into meaningful long-term survival.
4. Treatment-related harm
Some cancer therapies cause acute and long-term toxicity, including subsequent malignancies and organ damage. Their risks must be evaluated alongside demonstrated benefits.
5. How we measure treatment success
Tumor shrinkage, progression-free survival, and five-year survival cannot individually capture the full benefit of cancer care.
6. Quality of life
Longer survival should be evaluated alongside physical function, independence, symptom burden, and healthy survivorship.
7. Financial toxicity
Cancer care can impose major economic burdens on patients, families, and healthcare systems—particularly where access and financial protection are limited.
Introducing the Cancer Progress Scorecard
The paper proposes an eight-domain, patient-centered framework that considers prevention, mortality, durable treatment benefit, acute and late harm, subsequent malignancies, healthy survivorship, access and equity, and financial sustainability.
The scorecard is a proposed reporting framework, not a validated clinical scoring instrument.
The central message:
Real progress against cancer should mean fewer preventable cancers, fewer premature deaths, more healthy life, less treatment-related harm, and less financial injury.
[READ / DOWNLOAD THE LATEST 2026 CANCER MANUSCRIPT — UPLOAD LINK PENDING]
Critical narrative review. Publication and peer-review status are not yet verified. This manuscript does not establish the superiority of I-OM or any other therapeutic framework.
03 | I-OM Integrative Cancer Care Framework
Treat the Tumor. Support the Patient. Investigate the Root Drivers.
[EXPLORE THE I-OM CANCER CARE FRAMEWORK — LINK PENDING]
I-OM Systems Medicine proposes a broader research and care framework that considers both cancer-directed treatment and the health of the whole patient.
Core Elements
1. TPIM — Triple-Principle Integrative Medicine
A proposed organizing framework integrating tumor-directed interventions, underlying physiological disturbances, and whole-patient support.
2. Cancer Metabolism and Nutritional Strategies
-
Insulin resistance and metabolic dysfunction
-
Low-carbohydrate and ketogenic dietary approaches
-
Limitations of glucose and glutamine restriction
-
Maintaining adequate calories, protein, and muscle mass
-
Individualized metabolic assessment
3. Orthomolecular Nutrition
-
Identifying nutritional inadequacies and deficiencies
-
Nutritional support during treatment and recovery
-
Vitamins, minerals, protein, and other selected nutrients
-
Medication interactions, contraindications, and monitoring
4. Vitamin C and Investigational Cancer Strategies
-
Intravenous vitamin C: proposed mechanisms and clinical evidence
-
HDIVC and DP-HDIVC concepts
-
Redox and mitochondrial hypotheses
-
Safety screening and treatment limitations
-
Research priorities and clinical validation
5. Coordinated Whole-Patient Care
-
Conventional oncology treatment
-
Nutrition and metabolic management
-
Physical activity and rehabilitation
-
Symptom management and quality of life
-
Long-term survivorship
Important: Metabolic therapies and high-dose intravenous vitamin C remain investigational as cancer treatments. Clinical outcomes and safety must be established through appropriately designed research. They should not replace or delay effective oncology care.
The I-OM vision is to investigate how better understanding of patient biology may complement advances in cancer treatment.
04 | Cancer Nutrition & Metabolic Health
A Practical Public Guide for Patients and Families
[READ THE PUBLIC CANCER NUTRITION GUIDE — LINK PENDING]
Good nutrition is an important component of comprehensive cancer care.
This public-facing guide addresses:
-
Eating well during cancer treatment
-
Maintaining body weight and muscle strength
-
Adequate protein and essential nutrients
-
Metabolic health and blood glucose management
-
Safe physical activity and recovery
-
Nutritional challenges during chemotherapy and radiation
-
Questions to discuss with healthcare professionals
The goal is not simply to fight cancer—it is also to protect the strength and well-being of the person living with cancer.
Patients experiencing weight loss, poor appetite, or malnutrition should not undertake restrictive diets or fasting without qualified clinical supervision.
05 | I-OM Cancer Certificate Course
Continue Learning: From Cancer Biology to Integrative Care
[EXPLORE THE I-OM CANCER CERTIFICATE PROGRAM — LINK PENDING]
For clinicians, researchers, and healthcare professionals seeking more structured education, the I-OM Cancer Certificate Program offers 56 lessons covering:
-
Cancer biology and metabolism
-
Mitochondrial function and oxidative stress
-
Nutritional and orthomolecular medicine
-
Evidence and limitations of integrative approaches
-
Clinical safety and individualized care
-
Research interpretation and scientific reasoning
The program includes organized lessons, educational assessments, and a certificate pathway for eligible learners.
Learn the science. Question assumptions. Evaluate the evidence.
The course is separate from the free conference materials. Enrollment and certification requirements apply.
06 | Ask I-OM.ai — Cancer Q&A & Scientific Discussion
The Conference Does Not End with the Final Slide
[ASK A QUESTION / JOIN THE SCIENTIFIC DISCUSSION — LINK PENDING]
Our goal is to extend the conference into ongoing scientific exchange.
Through Ask I-OM.ai, participants can:
-
Ask questions about the keynote
-
Explore supporting research and references
-
Discuss cancer metabolism and integrative approaches
-
Critically examine evidence and competing hypotheses
-
Suggest research questions and collaborations
-
Follow future educational updates
Join the I-OM Community:
https://community.i-om.ai
Questions about personal cancer treatment require individualized assessment by qualified oncology professionals.
Join the Global I-OM Community
Connecting Science, Clinical Practice, and International Collaboration
I-OM Systems Medicine seeks to connect physicians, scientists, healthcare educators, and the public through evidence-informed research, education, and responsible scientific exchange.
We welcome discussion, constructive criticism, and international collaboration.
Our shared objective is to improve prevention, maximize meaningful treatment benefits, reduce avoidable harm, preserve quality of life, and make healthcare more sustainable.
Our Vision
Treat the Cancer. Support the Patient. Restore the Foundations of Health.
Cancer care should not be judged only by whether a tumor shrinks—but by whether patients live longer, healthier, and better lives.
The future of cancer medicine requires both scientific innovation and a broader commitment to the whole patient.
I-OM Systems Medicine
Connecting Biology, Nutrition, and Clinical Care
Scientific & Medical Disclaimer
This resource hub is intended for professional education, scientific exchange, and public health information. It does not provide individualized medical advice.
Established oncology interventions, supportive care practices, experimental therapies, and mechanistic hypotheses differ substantially in their levels of evidence.
The I-OM frameworks described here are intended to generate testable scientific questions; they do not establish that any specific integrative intervention improves cancer survival.
Patients should not discontinue, postpone, or replace recommended cancer treatment based on these materials. Dietary interventions, supplements, and investigational treatments require appropriate professional oversight.
Resource status: The public manuscript, conference slides, clinical framework, public guide, and course links will be activated once their publication destinations have been verified.